Related Experiment Videos
Angiomatoid fibrous histiocytoma
L D Grossman1, R R White, D A Arber
1Department of Plastic Surgery, Scott & White Clinic and Memorial Hospital, Temple, TX 76508, USA.
Annals of Plastic Surgery
|June 1, 1996
Summary
Angiomatoid fibrous histiocytoma (AFH) is a rare tumor distinct from malignant fibrous histiocytoma (MFH), typically affecting young individuals. Wide local removal is an effective treatment for this generally favorable soft-tissue mass.
Area of Science:
- Oncology
- Pathology
- Dermatology
Background:
- Angiomatoid fibrous histiocytoma (AFH) was previously classified as a variant of malignant fibrous histiocytoma (MFH).
- AFH is a rare fibrous tissue tumor with distinct clinical and pathological features.
- Recent classification designates AFH as a separate entity due to its unique characteristics.
Observation:
- AFH predominantly affects individuals under 20 years of age, contrasting with the typical seventh-decade presentation of MFH.
- Clinically, AFH presents as a soft-tissue mass, commonly found in the subcutis or deep dermal layers.
- Common locations for AFH include the extremities and neck.
Findings:
- AFH is characterized by its rarity and unique presentation in younger populations.
- Histologically, AFH differs from other MFH subtypes.
- Local recurrence of AFH has been documented.
Implications:
- The reclassification of AFH as a distinct entity aids in accurate diagnosis and understanding.
- Favorable mortality rates suggest a good prognosis for AFH.
- Wide local excision is considered sufficient treatment, indicating a generally benign clinical course.